These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23960165)

  • 1. Regulatory forum opinion piece: what are pathology raw data?
    Leininger JR; Parker GA
    Toxicol Pathol; 2014; 42(3):469-71. PubMed ID: 23960165
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulatory forum opinon piece: raw data in pathology--always a conundrum, often a controversy.
    Kerlin RL
    Toxicol Pathol; 2012 Jun; 40(4):695-6. PubMed ID: 22593233
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulatory forum opinion piece: Tox21 and toxicologic pathology.
    Bucher JR
    Toxicol Pathol; 2013 Jan; 41(1):125-7. PubMed ID: 22692375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory forum opinion piece*: pathology peer review--to lock or not to lock, is that really the question?
    Engelhardt JA; Hardisty JF; Mann PC
    Toxicol Pathol; 2013; 41(7):1051-2. PubMed ID: 23960166
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory forum opinion piece: Clarification and simplification of the pathology peer review documentation process.
    Tomlinson MJ; Leininger JR
    Toxicol Pathol; 2014; 42(2):309-10. PubMed ID: 24357643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory Forum Opinion Piece*: Dispelling Confusing Pathology Terminology: Recognition and Interpretation of Selected Rodent Renal Tubule Lesions.
    Seely JC; Frazier KS
    Toxicol Pathol; 2015 Jun; 43(4):457-63. PubMed ID: 25869578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory forum opinion piece: blind reading of histopathology slides in general toxicology studies.
    Neef N; Nikula KJ; Francke-Carroll S; Boone L
    Toxicol Pathol; 2012 Jun; 40(4):697-9. PubMed ID: 22407309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory forum opinion piece*: pathology peer review--dilemmas of documentation.
    Kerlin RL; Schafer KA
    Toxicol Pathol; 2013; 41(7):1049-50. PubMed ID: 23960162
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulatory forum opinion piece: thresholds in toxicologic pathology.
    Long GG; Hardisty JF
    Toxicol Pathol; 2012 Oct; 40(7):1079-81. PubMed ID: 22585940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory forum opinion piece: differences between protein-based biologic products (biotherapeutics) and chemical entities (small molecules) of relevance to the toxicologic pathologist.
    Leach MW
    Toxicol Pathol; 2013 Jan; 41(1):128-36. PubMed ID: 22744226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory Forum commentary: through the looking glass--SENDing the pathology data we have INHAND.
    Keenan CM; Goodman DG
    Toxicol Pathol; 2014 Jul; 42(5):807-10. PubMed ID: 23599411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory Forum opinion piece: image analysis-based cell proliferation studies using electronic images: the CEPA industry working group's proposal.
    Dölemeyer A; Mudry MC; Kohler M; Schorsch F
    Toxicol Pathol; 2013; 41(8):1170-3. PubMed ID: 23827979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory forum opinion piece: the role of the toxicologic pathologist in the postgenomic era: challenges and opportunities.
    Maronpot RR
    Toxicol Pathol; 2012 Oct; 40(7):1082-6. PubMed ID: 22585943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicologic Pathology Forum*: Opinion on Designation of Adverse and Nonadverse Histopathological Findings in Toxicity Studies: The Pathologist's Dilemma.
    Gopinath C; Mowat V
    Toxicol Pathol; 2019 Jul; 47(5):564-573. PubMed ID: 31291835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounders in interpreting pathology for safety and risk assessment.
    Wolf DC; Mann PC
    Toxicol Appl Pharmacol; 2005 Feb; 202(3):302-8. PubMed ID: 15667835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of the toxicologic pathologist in cancer research.
    Ward JM
    Toxicol Pathol; 2010 Jan; 38(1):39-42. PubMed ID: 19843952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory Forum Opinion Piece*: An Experienced Pathologist Need Not Always Be Present at Necropsy for Small Molecule or Biotherapeutic Safety Studies.
    Nikula KJ
    Toxicol Pathol; 2016 Jan; 44(1):12-3. PubMed ID: 26656238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXFOLIATIVE CYTOLOGY IN AN EXPERIMENTALLY INDUCED CARCINOMA OF THE HAMSTER CHEEK POUCH.
    STAHL SS
    Acta Cytol; 1963; 7():262-7. PubMed ID: 14058051
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulatory Forum Opinion Piece*: An Experienced Pathologist Should Be Present at Necropsy for Novel Medical Device Studies.
    Nikula KJ; Funk K
    Toxicol Pathol; 2016 Jan; 44(1):9-11. PubMed ID: 26656240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.